Results 181 to 190 of about 9,359 (237)

Insulin Glargine in Type 1 Diabetes Mellitus: A Review of Clinical Trials and Real-world Evidence Across Two Decades. [PDF]

Curr Diabetes Rev
Saboo B, Chandalia H, Ghosh S, Kesavadev J, Kochar IPS, Prasannakumar KM, Sarda A, Bantwal G, Mehrotra RN, Rai M.   +9 more
europepmc   +1 more source

Exenatide and glucagon co-infusion increases myocardial glucose uptake and improves markers of diastolic dysfunction in adults with type 2 diabetes. [PDF]

Sci Rep
Goodman J, Schain M, Di Stefano G, Lupson V, Horn T, Hill M, Manavaki R, Fryer TD, Bumanlag-Amis E, Jalaludeen N, Jermutus L, Johansson E, Heurling K, Haraldsson H, Evans M, Cheriyan J, Johansson L, Ambery P, Wilkinson IB.   +18 more
europepmc   +1 more source

Safety Outcomes After Sacubitril/Valsartan Initiation in a Community Teaching Hospital: A Retrospective Observational Study. [PDF]

Cureus
Anderson E, Jones J, Hintze T, Samuel N.
europepmc   +1 more source

Adverse drug events in cost-effectiveness models of pharmacological interventions for diabetes, diabetic retinopathy, and diabetic macular edema: a scoping review. [PDF]

JBI Evid Synth
Pesonen M, Jylhä V, Kankaanpää E.
europepmc   +1 more source

Continuous subcutaneous insulin infusion versus multiple daily injection therapy in pregnant women with type 1 diabetes. [PDF]

J Diabetes
Gong Y, Wei T, Liu Y, Wang J, Yan J, Yang D, Luo S, Weng J, Zheng X.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Insulin-detemir/insulin-lispro

Reactions Weekly, 2023
semanticscholar   +3 more sources